AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32205111 — intervention group
Group type: COMPARATOR
Intervention: Trainees
Number of subjects: 14
Study 32205111 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group participants deploying and closing the ProGlide closure device correctly without help
Number of subjects: 14
Study 32205111 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group participants' overall score improvement during training
Number of subjects: 14
Study 32205111 — intervention group
Group type: EXPERIMENTAL
Intervention: Time needed to complete the puncture and closure after training
Number of subjects: 14
Study 36153226 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone (DYD), total daily dose 40 mg
Number of subjects: 151
Study 36153226 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VAG), total daily dose 180 mg
Number of subjects: 151
Study 36153226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (IMP), total daily dose 100 mg
Number of subjects: 151
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Two drug regimens
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Three treatment-shortening strategies
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive ribavirin
Number of subjects: 0
Study 32423467 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjunctive ribavirin)
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups with very low cure rates (<60%)
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups with moderately low cure rates (80%)
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall true cure rate of 95%
Number of subjects: 0
Study 32423467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin comparison
Number of subjects: 0
Study 35001215 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) 4.5 mg orally at night, N=54
Number of subjects: 110
Study 35001215 — intervention group
Group type: COMPARATOR
Intervention: Placebo, N=56
Number of subjects: 110
Study 33225374 — intervention group
Group type: COMPARATOR
Intervention: Exercise advice and motivational support (Control group)
Number of subjects: 15
Study 32640411 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissociative seizures-specific cognitive behavioral therapy (CBT)
Number of subjects: 30
Study 32640411 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Medical Care (SMC)
Number of subjects: 30
Study 32084442 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound of the calcaneus measuring speed of sound (SOS), broadband ultrasound attenuation (BUA), and bone quality index (BQI)
Number of subjects: 1322
Study 32494883 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted thoracoscopic esophagectomy
Number of subjects: 20
Study 35798516 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 531
Study 35798516 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 531
Study 35798516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 531
Study 33927413 — intervention group
Group type: EXPERIMENTAL
Intervention: BPN14770 25 mg twice daily
Number of subjects: 30
Study 33927413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32560681 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent Housing and Support (IHS)
Number of subjects: 168
Study 32560681 — intervention group
Group type: COMPARATOR
Intervention: Residential Care Settings/Treatment as Usual (RCS/TAU)
Number of subjects: 168
Study 33452561 — intervention group
Group type: COMPARATOR
Intervention: Normal prophylactic antibiotic treatment given only on the day of surgery (Group A)
Number of subjects: 72
Study 33452561 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged antibiotic treatment given for 1 week after surgery (Group B)
Number of subjects: 72
Study 32899959 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP therapy
Number of subjects: 69
Study 32899959 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PRP and minoxidil
Number of subjects: 69
Study 32899959 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 69
Study 35492306 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 100
Study 35010953 — intervention group
Group type: EXPERIMENTAL
Intervention: American ginseng (AG) extract (1.6 g/day)
Number of subjects: 12
Study 35010953 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study 35673488 — intervention group
Group type: EXPERIMENTAL
Intervention: 220 mg/d ZnSO4 for 8 weeks
Number of subjects: 46
Study 32882310 — intervention group
Group type: EXPERIMENTAL
Intervention: Avacincaptad pegol 2 mg
Number of subjects: 286
Study 32882310 — intervention group
Group type: EXPERIMENTAL
Intervention: Avacincaptad pegol 4 mg
Number of subjects: 286
Study 32882310 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 286
Study 33446045 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-based child sexual abuse prevention program (5-week program with modules on emotional awareness, good touch-bad touch, and body safety rules)
Number of subjects: 290
Study 33446045 — intervention group
Group type: COMPARATOR
Intervention: Wait-list comparison group (no intervention)
Number of subjects: 290
Study 33446045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 290
Study 33446045 — intervention group
Group type: COMPARATOR
Intervention: Wait-list comparison group
Number of subjects: 290
Study 35819285 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric Orthokeratology (TOK)
Number of subjects: 30
Study 35819285 — intervention group
Group type: COMPARATOR
Intervention: Soft Toric Multifocal (STM)
Number of subjects: 30
Study 33208345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (6 monthly infusions)
Number of subjects: 110
Study 33208345 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 32787978 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Primary Healthcare (EnPHC) intervention
Number of subjects: 40
Study 32787978 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study 35554892 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Kangaroo Care (M-KC)
Number of subjects: 35
Study 35554892 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal Kangaroo Care (F-KC)
Number of subjects: 35
Study 35554892 — intervention group
Group type: COMPARATOR
Intervention: Incubator (before KC)
Number of subjects: 35
Study 35554892 — intervention group
Group type: COMPARATOR
Intervention: Incubator (after KC)
Number of subjects: 35
Study 35208573 — intervention group
Group type: COMPARATOR
Intervention: Single-leg hopping in long-term treated Wilson patients
Number of subjects: 29
Study 34368890 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPOX (capecitabine plus oxaliplatin) plus bevacizumab
Number of subjects: 47
Study 33115534 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to longer telomere length (measured by polygenic score)
Number of subjects: 339
Study 33115534 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to longer telomere length
Number of subjects: 339
Study 35909321 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines at Transitions of care Intervention (MaTI) including a patient-held My Medicines Toolkit, enhanced communication with community pharmacists, and increased engagement of community pharmacists post-discharge.
Number of subjects: 0
Study 34166370 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 750 mg twice/day (n = 119)
Number of subjects: 233
Study 34166370 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA) 75 to 125 mg/day (n = 114)
Number of subjects: 233
Study 34166370 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 233
Study 34166370 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 233
Study 34166370 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined events
Number of subjects: 233
Study 34166370 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-year glomerular filtration rate (GFR)
Number of subjects: 233
Study 34166370 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 233
Study 32532262 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT) during early pulmonary rehabilitation
Number of subjects: 0
Study 32532262 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 0
Study 35033133 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM)
Number of subjects: 210
Study 35033133 — intervention group
Group type: COMPARATOR
Intervention: No continuous passive motion (no-CPM)
Number of subjects: 210
Study 35487978 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) using PREVENA dressings applied for 7 days
Number of subjects: 0
Study 35487978 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressings applied immediately upon completion of surgery
Number of subjects: 0
Study 35487978 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 0
Study 35487978 — intervention group
Group type: COMPARATOR
Intervention: Conventional dressings
Number of subjects: 0
Study 32276301 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses (BB)
Number of subjects: 43
Study 32276301 — intervention group
Group type: COMPARATOR
Intervention: Placebo (clear glasses)
Number of subjects: 43
Study 34894361 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship care plans (SCPs)
Number of subjects: 74
Study 33155862 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training intervention (INT) consisting of an interactive training session and four joint visits with communication coaches
Number of subjects: 22
Study 33155862 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 22
Study 32051084 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM) intensive training
Number of subjects: 70
Study 32051084 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental training combined with ESDM intensive training
Number of subjects: 70
Study 32051084 — intervention group
Group type: COMPARATOR
Intervention: Parental training
Number of subjects: 70
Study 34724172 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg bimatoprost implant
Number of subjects: 528
Study 34724172 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 µg bimatoprost implant
Number of subjects: 528
Study 34724172 — intervention group
Group type: COMPARATOR
Intervention: Topical timolol maleate 0.5% (Control)
Number of subjects: 528
Study 34724172 — intervention group
Group type: COMPARATOR
Intervention: Topical timolol (Control)
Number of subjects: 528
Study 32234665 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib daily (arm 1)
Number of subjects: 44
Study 32234665 — intervention group
Group type: COMPARATOR
Intervention: Fluoropyrimidine therapy (infusional 5‐fluorouracil or oral capecitabine, arm 2)
Number of subjects: 44
Study 34716571 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamycin and ampicillin, injected intravenously for 4 days.
Number of subjects: 71
Study 34199802 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant vitamin D3 (100,000 IU every 50 days)
Number of subjects: 104
Study 34199802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 34392162 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (AG) receiving repetitive Transcranial Magnetic Stimulation (rTMS) during cognitive stimulation sessions
Number of subjects: 22
Study 34392162 — intervention group
Group type: COMPARATOR
Intervention: Sham group (SG) receiving sham stimulation during cognitive stimulation sessions
Number of subjects: 22
Study 32928218 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish version of the EHP-30
Number of subjects: 211
Study 33940204 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal stress (toxic stress)
Number of subjects: 32
Study 33940204 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from family, infants, health care providers, social service programs, and community organizations
Number of subjects: 32
Study 33940204 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal stress responses
Number of subjects: 32
Study 34444492 — intervention group
Group type: EXPERIMENTAL
Intervention: FL + FD + PG
Number of subjects: 538
Study 32109935 — intervention group
Group type: EXPERIMENTAL
Intervention: Remitted psychotic depression patients
Number of subjects: 245
Study 32109935 — intervention group
Group type: EXPERIMENTAL
Intervention: Insular‐limbic network
Number of subjects: 245
Study 32109935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectional depression and severity scores
Number of subjects: 245
Study 36326594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyramidal + Plyometric Training (PYR + PLY)
Number of subjects: 60
Study 36326594 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarized + Plyometric Training (POL + PLY)
Number of subjects: 60
Study 36326594 — intervention group
Group type: COMPARATOR
Intervention: Pyramidal (PYR)
Number of subjects: 60
Study 36326594 — intervention group
Group type: COMPARATOR
Intervention: Polarized (POL)
Number of subjects: 60
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (including atherectomy, drug coated balloons, stenting)
Number of subjects: 89
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 89
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: Orbital atherectomy
Number of subjects: 89
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: Jetstream
Number of subjects: 89
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 89
Study 32921595 — intervention group
Group type: EXPERIMENTAL
Intervention: SilverHawk/TurboHawk
Number of subjects: 89
Study 32632732 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted ERAS
Number of subjects: 35
Study 32632732 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 35
Study 33236669 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model
Number of subjects: 80
Study 33236669 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 32969628 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional brioche containing wheat bran and bergamot fiber
Number of subjects: 11
Study 32969628 — intervention group
Group type: COMPARATOR
Intervention: Classic brioche
Number of subjects: 11
Study 34870331 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 44
Study 34870331 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth sub- and supragingival instrumentation using scalers and curets
Number of subjects: 44
Study 33914047 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release verapamil plus trandolapril
Number of subjects: 16688
Study 33274552 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation in mice; no specific dosage or duration mentioned.
Number of subjects: 0
Study 33274552 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation in humans with overweight or obesity; no specific dosage or duration mentioned.
Number of subjects: 0
Study 32279446 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 542
Study 32279446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study 36189668 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupillometry-controlled administration of sufentanil
Number of subjects: 61
Study 36189668 — intervention group
Group type: COMPARATOR
Intervention: Free-choice administration of sufentanil by anesthesiologists
Number of subjects: 61
Study 33602798 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 45
Study 33602798 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect Video Laryngoscopy (IVL)
Number of subjects: 45
Study 33602798 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Reality-Assisted Video Laryngoscopy (ARVL)
Number of subjects: 45
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyberbullying involvement (victim or perpetrator)
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Family cohesion
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: School cohesion
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactions in regression models
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female students)
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade level (higher grade)
Number of subjects: 4978
Study 33271852 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic performance (worse performance)
Number of subjects: 4978
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% fluorouracil
Number of subjects: 624
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod
Number of subjects: 624
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: methylaminolevulinate photodynamic therapy
Number of subjects: 624
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.015% ingenol mebutate gel
Number of subjects: 624
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe AK (Olsen grade III)
Number of subjects: 624
Study 35475852 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe AK (Olsen grade III) with additional treatment
Number of subjects: 624
Study 32227613 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0
Study 32227613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36107583 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Mindfulness Training (MMT) for 4 weeks
Number of subjects: 45
Study 36107583 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control (WLC) group, no intervention
Number of subjects: 45
Study 34154426 — intervention group
Group type: EXPERIMENTAL
Intervention: bundle of interventions to treat postpartum haemorrhage
Number of subjects: 80
Study 34154426 — intervention group
Group type: EXPERIMENTAL
Intervention: monitor sample size assumptions
Number of subjects: 80
Study 34154426 — intervention group
Group type: EXPERIMENTAL
Intervention: monitoring for adherence
Number of subjects: 80
Study 33351387 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline supplementation
Number of subjects: 16
Study 33351387 — intervention group
Group type: COMPARATOR
Intervention: No citrulline supplementation (Control group)
Number of subjects: 16
Study 35727586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg on day 1 followed by 90 mg twice daily on days 2-90) plus aspirin (75-300 mg on day 1 followed by 75 mg daily for 21 days)
Number of subjects: 6412
Study 35727586 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300 mg on day 1 followed by 75 mg daily on days 2-90) plus aspirin (75-300 mg on day 1 followed by 75 mg daily for 21 days)
Number of subjects: 6412
Study 35727586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor and aspirin
Number of subjects: 6412
Study 34531495 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy
Number of subjects: 84
Study 34230018 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT: GROw
Number of subjects: 48
Study 34230018 — intervention group
Group type: COMPARATOR
Intervention: face‐to‐face CBT treatment
Number of subjects: 48
Study 32674009 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) with usual care (exercise and orthotic support)
Number of subjects: 44
Study 32674009 — intervention group
Group type: COMPARATOR
Intervention: Usual care (exercise and orthotic support)
Number of subjects: 44
Study 33641414 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Superior Approach (DSA)
Number of subjects: 100
Study 33008455 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice Facilitation (PF) as a quality improvement strategy for implementing TASSH
Number of subjects: 700
Study 35409571 — intervention group
Group type: EXPERIMENTAL
Intervention: Athletics
Number of subjects: 90
Study 35409571 — intervention group
Group type: EXPERIMENTAL
Intervention: Handball
Number of subjects: 90
Study 35409571 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 34491840 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine administered one day before exposure to hyperopic blur
Number of subjects: 20
Study 34491840 — intervention group
Group type: COMPARATOR
Intervention: Placebo/hyperopic (-3 D) blur
Number of subjects: 20
Study 34491840 — intervention group
Group type: COMPARATOR
Intervention: Placebo/no blur
Number of subjects: 20
Study 34491840 — intervention group
Group type: COMPARATOR
Intervention: Placebo/hyperopic blur one day after administration of 0.01% atropine
Number of subjects: 20
Study 32790725 — intervention group
Group type: EXPERIMENTAL
Intervention: Wawamum (50 grams/day)
Number of subjects: 870
Study 32790725 — intervention group
Group type: COMPARATOR
Intervention: Standard government health services
Number of subjects: 870
Study 34999333 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate counting
Number of subjects: 75
Study 34999333 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate counting combined with DASH
Number of subjects: 75
Study 34999333 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 75
Study 33385439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 21
Study 35871319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross trainer exercise starting 3 days postoperatively
Number of subjects: 50